Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Turner And Klinefelter Treatment Target Study. Improving Endocrine Treatment by Linking Biochemical Parameters to Morbidity and Quality of Life in Patients With Turner and Klinefelter Syndrome

NCT04803474 is registered in ClinicalTrials.gov with dr. Laura C. G. de Graaff-Herder as lead sponsor.

NCT NCT04803474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04803474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Turner And Klinefelter Treatment Target Study. Improving Endocrine Treatment by Linking Biochemical Parameters to Morbidity and Quality of Life in Patients With Turner and Klinefelter Syndrome
Lead sponsor
dr. Laura C. G. de Graaff-Herder
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2018
Completion date
December 1, 2024
Enrollment
370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

klinefelter syndrome, turner syndrome